|
Motor vehicle crashes are a leading cause of trauma-related deaths, often resulting from severe bleeding. The potential impact of prehospital blood transfusion in such scenarios
is substantial, as early intervention could improve survival rates.
There is a pressing need for a systematic review of the existing literature on prehospital blood transfusion. This review would critically assess the available studies, evaluating
the efficacy, safety and risks of administering blood transfusions in the prehospital environment.
An interagency agreement between NHTSA and the Agency for Healthcare Research and Quality (AHRQ) will fund a systematic review on EMS prehospital blood transfusion. AHRQ recently
posted several key questions for public comment that will inform the systematic review. The systematic review results will serve as a resource for prehospital care evidence-based guidelines, protocols, and state and local EMS agency decision-making.
The comment form for the AHRQ Prehospital EMS Blood Transfusion Systematic Review key questions is available for your input through
Tuesday, June 18, 2024.
The NHTSA Office of Emergency Medical Services (OEMS) mission is to reduce death and disability by providing leadership and coordination to the EMS community in assessing, planning,
developing and promoting comprehensive, evidence-based emergency medical services systems.
NHTSA is the federal leader for motor vehicle and traffic safety, with a history of successfully promoting and advancing injury prevention in its policies, programs and practices.
EMS also plays a significant role in ensuring the safety and care of crash victims across the nation's highways and roadways. The U.S. Department of Transportation's (DOT) 2022 National Roadway Safety Strategy (NRSS) emphasizes a safe system approach that
identifies post-crash care as one of five key objectives in creating a transportation system that’s safe for all people.
|
